Immuneering Corporation (IMRX) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of Immuneering Corporation and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMRX
Immuneering Corporation
$3.87HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
TARA
Protara Therapeutics, Inc.
$2.55HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
Total return — IMRX vs TARA
growth of $100 · dividends reinvested · last 5yIMRX -77.0% (-25.5%/yr)TARA -66.8% (-19.8%/yr)TARA compounded faster over this window
IMRX TARA
IMRX vs TARA: by the numbers
- •TARA is the larger company ($143M vs $140M market cap).
Metrics side by side
Valuation
| Metric | IMRX | TARA |
|---|---|---|
| P/B ratio | 0.74 | 0.89 |
Profitability
| Metric | IMRX | TARA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -30.03% | -43.40% |
| ROIC | -32.73% | -47.18% |
Growth (annualized)
| Metric | IMRX | TARA |
|---|---|---|
| Total return CAGR (5Y) | -32.77% | -16.45% |
Frequently asked
- How have IMRX and TARA total returns compared?
- Over the past 5 years, IMRX delivered -32.77% and TARA delivered -16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.